Why Does My GLP-1 Feel Stronger Some Weeks Than Others?

Monday:

“I could not possibly eat another bite.”

Saturday:

opens pantry

“Interesting.”

If you've ever had one GLP-1 week feel completely different from another, you are very much not alone in wondering what is going on.

Maybe your appetite felt noticeably quieter last week.

Maybe this week you're hungrier.

Maybe the day after your injection feels different from the day before the next one.

And naturally, the thought appears:

Is this thing even working anymore?

Your medication has not necessarily resigned.

Weekly GLP-1-based medications are designed to remain in the body for days, not hours. But the amount of medication circulating in your body isn't perfectly identical every minute of every day.

That can help explain part of the story.

It does not explain every hungry Tuesday.

Does a weekly GLP-1 actually “wear off” before the next shot?

Not in the way people often mean when they say it.

Weekly medications such as semaglutide and tirzepatide have long half-lives.

A half-life is roughly the amount of time it takes for the amount of a drug in the body to decrease by half.

It does NOT mean:

“the medication works for exactly this many days and then switches off.”

Semaglutide has an elimination half-life of approximately one week.

Tirzepatide has an elimination half-life of approximately five days.

That long persistence is part of what makes once-weekly dosing possible.

Drug concentration can rise after an injection and gradually decline before the next dose.

But declining is not the same thing as disappearing.

And this is where internet explanations tend to get a little too tidy.

So why might the end of the week feel different?

Here's where we have to separate:

What pharmacology tells us

from:

What people notice.

We know that drug concentrations change during a weekly dosing interval.

We know these medications can influence appetite, fullness and food intake.

What we do NOT have is a neat clinical rule saying:

Day 1 = no hunger
Day 4 = a little hunger
Day 7 = pantry raid

Human appetite is considerably more annoying than that.

Sleep can affect hunger.

Stress can affect hunger.

Activity can affect hunger.

What and how much you've eaten can affect hunger.

Hormonal changes can affect hunger.

Your dose and where you are in dose escalation may matter.

And sometimes:

you are simply hungry.

That last one deserves more attention than it gets.

Wait. Am I not supposed to be hungry?

No.

And this may be one of the most useful things to understand about GLP-1 treatment.

These medications can meaningfully reduce appetite.

That effect is supported by clinical research.

In a randomized trial of adults with obesity, semaglutide 2.4 mg reduced hunger, increased fullness and satiety, improved control of eating and reduced ad libitum energy intake compared with placebo.

But “reduced hunger” is not the same thing as:

“a human being should never feel hungry again.”

If you wake up hungry, your medication has not necessarily failed.

If you want lunch, your medication has not necessarily failed.

If you have a week where food sounds more appealing than it did last week, your medication has not necessarily failed.

The goal is not to achieve the appetite of a decorative houseplant.

Why can one week feel stronger than another?

Because your injection is not the only variable in your life.

This is the part that's easy to forget when you're paying close attention to medication.

Think about two different weeks.

Week one:

You slept well.

Work was relatively normal.

You ate regular meals.

You weren't particularly active.

Your stomach behaved itself.

Week two:

You slept five hours.

Work became a small dumpster fire.

You exercised more.

You skipped lunch twice.

Your period is approaching.

You spent Wednesday surviving on coffee and optimism.

Those weeks may not produce identical hunger.

That doesn't mean the medication changed.

Your life did.

There are also medication-related reasons weeks may genuinely feel different.

Dose escalation can change drug exposure.

Early treatment is different from established treatment.

And concentrations accumulate over repeated weekly dosing until steady state is reached.

So yes:

there is pharmacology happening.

But there is also a whole person attached to the injection pen.

What is “steady state,” and why should I care?

This sounds considerably more dramatic than it is.

When you take a long-acting medication repeatedly, some of the previous dose is still in your body when the next dose arrives.

Over time, the amount builds toward a relatively consistent range.

That's called steady state.

For tirzepatide, prescribing information reports that steady-state plasma concentrations are reached after approximately four weeks of once-weekly administration.

This is one reason your first injection should not be treated as a preview of exactly how every future week will feel.

Your body and medication exposure are still settling into a pattern.

And if the dose changes?

The pattern has another adjustment to make.

Did your dose just change?

Why Do GLP-1 Side Effects Feel Worse After a Dose Increase?

→

Does the day after my injection really have more medication in my body?

Drug concentration does change after an injection.

For tirzepatide, the median time to maximum plasma concentration is approximately 24 hours, with a reported range of about 8 to 72 hours.

But please do not turn that into:

“My appetite should be lowest exactly 24 hours after my shot.”

Pharmacokinetics tells us what happens to drug concentration across groups of people.

It does not give us a stopwatch for an individual person's hunger.

Your stomach did not receive the graph.

What if I suddenly feel much hungrier than I used to?

First:

don't panic over one day.

Or one meal.

Or one weekend where your appetite apparently remembered its password.

Look for a pattern.

Ask:

• Has this been happening consistently for several weeks?
• Did it begin after a schedule disruption or missed dose?
• Did something change with your sleep, stress, activity or routine?
• Are you actually eating enough earlier in the day?
• Did your medication or dose change?
• Are you comparing normal hunger now with almost no hunger during an earlier period?

That last question can be especially useful.

When you've experienced very strong appetite suppression, normal hunger can feel surprisingly loud by comparison.

If you notice a persistent, meaningful change in how the medication feels or have questions about whether your dose is appropriate, talk with your prescriber.

Do not independently increase your dose.

Do not take your next injection early because Tuesday was snackier than expected.

Your dosing schedule is not a mood board.

Can I change my injection day?

That depends on your medication. The answer comes from its own prescribing information, not from one universal GLP-1 rule.

Zepbound (tirzepatide): The prescribing information says the day of weekly administration can be changed, if necessary, as long as the time between the two doses is at least 3 days (72 hours). If a dose is missed, it says to take it as soon as possible within 4 days (96 hours) after the missed dose.

Wegovy (semaglutide injection): The prescribing information says to inject once weekly on the same day each week. It allows the time of day to change, but it does not give instructions for moving the injection day. If a dose is missed and the next scheduled dose is more than 2 days away, it says to take the missed dose as soon as possible; if the next dose is less than 2 days away, skip the missed dose and resume on the regularly scheduled day. If 2 or more doses in a row are missed, the label directs prescribers to restart dose escalation at a lower dose.

Other medications and formulations have their own instructions, so check yours and ask your pharmacist or prescriber if anything is unclear.

If you're considering moving your injection day because you feel the medication is “wearing off,” talk with your prescriber or pharmacist rather than repeatedly moving doses around in an attempt to chase appetite suppression.

What should I actually pay attention to?

When should I talk to my prescriber?

Talk with your prescriber if:

• you notice a persistent and meaningful change in how the medication feels;
• you are unsure whether your current dose is appropriate;
• you missed doses and aren't sure how to restart;
• side effects are becoming difficult to manage;
• you are considering changing the dosing schedule;
• you have questions about whether another medication or health issue could be affecting appetite.

Do not independently increase your dose or shorten the interval between injections to try to recreate stronger appetite suppression.

If something feels significantly different, bring the pattern to the person managing the prescription.

That's considerably more useful than trying to reverse-engineer your pharmacokinetics from Thursday's snack drawer.

The Takeaway

Yes, a weekly GLP-1 can feel different at different points in treatment — and one week may not feel exactly like the next.

There is real pharmacology behind weekly dosing.

Semaglutide and tirzepatide stay in the body for days, drug concentrations change between injections and repeated dosing eventually produces a more stable range of exposure.

But that does not give us a clinical rule saying your medication “wears off” on a particular day.

And hunger is not proof that it stopped working.

Sleep, stress, activity, eating patterns, dose changes, GI symptoms and ordinary human appetite can all change what you notice from week to week.

Look for patterns rather than judging the medication by one hungry afternoon.

And if that pattern changes meaningfully or persistently, bring it to your prescriber.

Your medication has not necessarily resigned.

Sometimes you just wanted lunch.

Sources & Further Reading

U.S. Food and Drug Administration. WEGOVY (semaglutide) prescribing information. Novo Nordisk. Revised 6/2026. Elimination half-life approximately 1 week; once-weekly administration on the same day each week; missed-dose instructions (section 2.4).
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b

U.S. Food and Drug Administration. ZEPBOUND (tirzepatide) prescribing information. Eli Lilly and Company. Revised 8/2026. Half-life approximately 5 days; median time to maximum concentration 24 hours (range 8 to 72 hours); steady state after 4 weeks of once-weekly administration; changing the administration day and missed-dose instructions.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b

Friedrichsen M, Breitschaft A, Tadayon S, Wizert A, Skovgaard D. The effect of semaglutide 2.4 mg once weekly on energy intake, appetite, control of eating, and gastric emptying in adults with obesity. Diabetes, Obesity and Metabolism. 2021;23(3):754–762. doi:10.1111/dom.14280. PMID: 33269530.
https://pmc.ncbi.nlm.nih.gov/articles/PMC7898914/